The Effect of an Antioxidant Gel Compared to Chlorhexidine Gel During the Soft Tissue Healing Process: A Randomized Controlled Clinical Trial
Launched by KUWAIT UNIVERSITY · Mar 19, 2025
Trial Information
Current as of May 09, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two different gels—an antioxidant gel and chlorhexidine gel—on healing after a dental procedure called scaling and root planing (SRP), which is used to treat serious gum disease known as periodontitis. The goal is to see which gel helps patients heal better and reduces complications after the procedure by looking at certain markers in the body that indicate inflammation and healing.
To participate in this trial, patients need to have Stage 3 or 4 periodontitis, which means they have significant gum disease with specific symptoms like bleeding gums and deep pockets around the teeth. However, individuals with milder gum issues, certain health conditions (like diabetes or cancer), smokers, or those who have recently used specific medications are not eligible. Participants in the trial will use one of the two gels after their dental treatment, and researchers will monitor their healing progress. This study aims to help dentists choose the best postoperative care to improve healing and long-term gum health for their patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with Stage 3 or 4 periodontitis would be invited to participate in this study.
- • The following parameters will be used for the diagnosis of periodontitis: (a) presence of bleeding on gentle probing; (b)probing depth (PD) \>6mm; and (c) marginal bone loss (MBL) of at least 3.
- Exclusion Criteria:
- • Patients will be excluded from the study if they present with gingivitis alone, are currently using oral contraceptives, have systemic conditions such as diabetes or cancer, or are smokers (including those who quit within the past 6 months).
- • Recent antibiotic use within the last 3 months, NSAID or bisphosphonate use within the last 90 days, and any use of chlorhexidine in the past 6 months.
About Kuwait University
Kuwait University is a leading institution dedicated to advancing medical research and education in the region. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct innovative research aimed at improving healthcare outcomes. Committed to ethical standards and rigorous scientific methodology, Kuwait University collaborates with a diverse range of stakeholders, including researchers, healthcare professionals, and industry partners, to facilitate cutting-edge clinical trials that address pressing health challenges. Through its initiatives, the university aims to contribute significantly to the body of medical knowledge and enhance the quality of patient care in Kuwait and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuwait City, , Kuwait
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported